Literature DB >> 30631111

Are women with pathogenic variants in PMS2 and MSH6 really at high lifetime risk of breast cancer?

D G Evans1,2, E R Woodward3,4, F Lalloo3, P Møller5, J Sampson6, J Burn7, G Moeslein8, G Capella9.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30631111     DOI： 10.1038/s41436-018-0401-1

Source DB:  PubMed          Journal:  Genet Med        ISSN： 1098-3600            Impact factor:   8.822


× No keyword cloud information.
  2 in total

1.  Lynch Syndrome and Breast Cancer Risk: Weighing the Data.

Authors:  Wendy Kohlmann
Journal:  JCO Precis Oncol       Date:  2020-02-26

2.  Lynch Syndrome Germline Mutations in Breast Cancer: Next Generation Sequencing Case-Control Study of 1,263 Participants.

Authors:  Aleksey G Nikitin; Daria A Chudakova; Rafael F Enikeev; Dina Sakaeva; Maxim Druzhkov; Leyla H Shigapova; Olga I Brovkina; Elena I Shagimardanova; Oleg A Gusev; Marat G Gordiev
Journal:  Front Oncol       Date:  2020-05-29       Impact factor: 6.244
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.